Text Messaging for Heart Failure
(TEXT4HF Trial)
Trial Summary
What is the purpose of this trial?
The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answer are: * Is a tailored text messaging intervention feasible and acceptable among older adult patients with heart failure? * Does tailored text messaging improve self-care in adult patients with heart failure? Participants will be randomly assigned to one of two groups for 12 weeks: 1) intervention (text messaging); or 2) control group. Both groups will receive usual care, which includes regular follow-up visits at the heart failure clinic (standard care), plus a "Discharge Packet for Patients Diagnosed with Heart Failure", developed by the American Heart Association. Both groups will be asked via text messages and/or telephone calls to complete questionnaires at baseline/start, 4 weeks and 12 weeks, about self-care, quality of life, health beliefs, medications, diet, etc. Participants assigned to the intervention group will also receive approximately 5 text messages/week targeting medication adherence, heart-healthy diet, and daily HF symptoms monitoring for 12 weeks.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. It seems like you will continue with your usual care, which includes your regular medications.
What data supports the effectiveness of the treatment TEXT4HF for heart failure?
Is text messaging for heart failure safe for humans?
How is the TEXT4HF treatment different from other heart failure treatments?
TEXT4HF is unique because it uses text messaging to improve self-care behaviors in heart failure patients, helping them manage their condition better after leaving the hospital. Unlike traditional treatments that focus on medication or devices, this approach emphasizes patient engagement and education through mobile technology.1361011
Research Team
Jonathan W Leigh, MPH, MSHI
Principal Investigator
University of Illinois Chicago
Spyros Kitsiou, PhD
Principal Investigator
University of Illinois Chicago
Eligibility Criteria
This trial is for older adults with heart failure who can receive text messages and are willing to participate in a study for 12 weeks. They should be able to complete questionnaires via text or phone calls. There's no specific mention of exclusion criteria provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline questionnaires about self-care, quality of life, health beliefs, medications, and diet
Intervention
Participants receive tailored text messages targeting medication adherence, heart-healthy diet, and daily HF symptoms monitoring
Follow-up
Participants are monitored for changes in self-care and health beliefs through questionnaires at 4 and 12 weeks
Treatment Details
Interventions
- TEXT4HF
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor